E.M.E. Coerver

Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis

E.M.E. Coerver, A. Bourass, M.H.J. Wessels et al. · Multiple Sclerosis and Related Disorders · 2023 · 20 citations · Full text

Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long‐term follow‐up

E.M.E. Coerver, Sophie Janssens, Aroosa Ahmed et al. · European Journal of Neurology · 2023 · 18 citations · Full text

The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis

C.A.A. van ‘t Hullenaar, E.M.E. Coerver, Nynke F. Kalkers et al. · Multiple Sclerosis and Related Disorders · 2021 · 10 citations

Disease Progression, Multi-domain Patient, Clinical Disease Progression +8

Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis

Eva Strijbis, E.M.E. Coerver, Jop Mostert et al. · Journal of Neurology Neurosurgery & Psychiatry · 2023 · 10 citations